AEBP1 and neoplasm: Moreover, AEBP1 silencing was accompanied by impaired nuclear translocation of NF-κB/p65 and inhibited expression of CXCR4 and ICAM-1, downstream targets of NF-κB signaling that are involved in tumor growth, invasion, and metastasis.